Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Class 'A' Ordinary Shares
-
Shares outstanding
-
385,837,333
-
Total 13F shares
-
10,629,465
-
Share change
-
-1,187,772
-
Total reported value
-
$12,858,000
-
Price per share
-
$1.21
-
Number of holders
-
24
-
Value change
-
-$2,017,166
-
Number of buys
-
6
-
Number of sells
-
17
Institutional Holders of Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) as of Q3 2019
As of 30 Sep 2019,
Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) was held by
24 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,629,465 shares.
The largest 10 holders included
STONEHILL CAPITAL MANAGEMENT LLC, Paradice Investment Management LLC, HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC, FIRST WILSHIRE SECURITIES MANAGEMENT INC, JANUS HENDERSON GROUP PLC, Fondren Management LP, RENAISSANCE TECHNOLOGIES LLC, HEARTLAND ADVISORS INC, MORGAN STANLEY, and Adirondack Research & Management Inc..
This page lists
24
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.